Purchase this article with an account.
Gaston Gomez Caride, Sr., Leonardo Ferlini, Gerardo Valvecchia, Albertazzi Roberto, Zanutigh Virginia, Perrone Luciano, Perrone Daniel, Marcelo Zas, Sr.; Outcomes Of 23-gauge Vitrectomy For Diabetic Vitreous Hemorrhage : A Case Series. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2629.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the efficacy and safety of 23-gauge transconjunctival sutureless vitrectomy (23-G TSV) in the management of diabetic vitreous hemorrhage in our series.
Single-center, retrospective, noncomparative series of 20 eyes (20 patients) with diabetic vitreous hemorrhage. All patients underwent pars plana 23-gauge vitrectomy, endolaser panphotocoagulation and perfluoropropane gas (C3F8) was used in all cases, peeling was performed in two cases. All patients had at least 6-month follow-up. Main outcome measures included visual acuity (VA), intraocular pressure (IOP), and intraoperative and postoperative complications.
Mean overall VA was 0.025 (0.001 perception to 0.4) preoperatively and 0.197 (range 0.001 to 0.8) postoperatively. Mean IOP was 14.65 (range 10-22 mmHg) preoperatively and 15.85 mmHg (range 8-26 mmHg) at 6 months postoperatively. Concerning complications, rhegmatougenous retinal detachment occurred in one eye in the series.
23-gauge transconjunctival sutureless vitrectomy offers a safe surgical technique and with fewer intraoperative complications been feasible for the treatment for diabetic vitreous hemorrhage.
This PDF is available to Subscribers Only